ARTA
ELOS

A.R.T. Advisors’s Syneron Medical Ltd ELOS Stock Holding History

A.R.T. Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,400
Closed -$120K – 1951
2017
Q1 		$120K Buy
+11,400
New +$110K 0.01% 1247
2015
Q4 		– Sell
-15,429
Closed -$110K – 1888
2015
Q3 		$110K Sell
15,429
-839
-5% -$8.06K ﹤0.01% 1240
2015
Q2 		$172K Sell
16,268
-2,732
-14% -$32K 0.01% 1302
2015
Q1 		$235K Buy
19,000
+7,887
+71% +$87.3K 0.01% 1181
2014
Q4 		$103K Buy
+11,113
New +$107K ﹤0.01% 1302
2014
Q3 		– Sell
-10,738
Closed -$110K – 1682
2014
Q2 		$110K Sell
10,738
-2,650
-20% -$28.6K 0.01% 1209
2014
Q1 		$166K Buy
13,388
+3,380
+34% +$40K 0.01% 1176
2013
Q4 		$123K Sell
10,008
-9,115
-48% -$94.7K 0.01% 1175
2013
Q3 		$164K Sell
19,123
-13,300
-41% -$115K 0.01% 1168
2013
Q2 		$282K Buy
+32,423
New +$290K 0.01% 1055

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

A.R.T. Advisors's ELOS Position: Q2 2017 in Review

A.R.T. Advisors sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 11,400 shares — an estimated $120K sold.

A.R.T. Advisors first reported a position in ELOS in Q2 2013 and held it in 10 quarters. The position peaked at $282K in Q2 2013. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • A.R.T. Advisors reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 11,400 Syneron Medical Ltd shares in Q2 2017, an estimated $120K.
  • A.R.T. Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 10 quarters.
  • A.R.T. Advisors's Syneron Medical Ltd position peaked at $282K in Q2 2013.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.